Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 256Carcinoma, Non-Small-Cell Lung 212Ovarian Neoplasms 134Lung Neoplasms 107Esophageal Neoplasms 69Triple Negative Breast Neoplasms 64Stomach Neoplasms 58Fallopian Tube Neoplasms 56Squamous Cell Carcinoma of Head and Neck 52Neoplasm Metastasis 50Head and Neck Neoplasms 44Esophageal Squamous Cell Carcinoma 43Carcinoma, Ovarian Epithelial 42Neoplasms 36Endometrial Neoplasms 34Uterine Cervical Neoplasms 32Recurrence 29Adenocarcinoma Of Esophagus 24Adenocarcinoma of Lung 22Urinary Bladder Neoplasms 21Melanoma 20Carcinoma, Squamous Cell 19Carcinoma 18Small Cell Lung Carcinoma 17Prostatic Neoplasms 15Breast Neoplasms, Male 15Adenocarcinoma, Bronchiolo-Alveolar 13Peritoneal Neoplasms 12Inflammatory Breast Neoplasms 12Testicular Neoplasms 10

Interventions

Dexamethasone 12Palonosetron 11Aprepitant 11Ondansetron 8Olanzapine 5Calcium Dobesilate 4netupitant 2fosaprepitant 2Tropisetron 2Radiotherapy 2Fluorouracil 2yangzheng xiaoji 1rolapitant 1ramosetron 1niraparib 1netupitant, palosentron drug combination 1nabiximols 1isatuximab 1ginger extract 1dolasetron 1casopitant 1Yoga 1Therapeutics 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiation 1Paclitaxel 1Oxaliplatin 1Octreotide 1Midazolam 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Nausea × Paclitaxel × Clear all
NCT02290470 2014-11-14

Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
81 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡